Hormonal Contraceptive Market Size, Share, Trends, Industry Analysis Report: By Product, By Hormone, By Distribution Channel, and By Region - Market Forecast, 2024

Description

List of Tables

The global hormonal contraceptive market size is expected to reach USD 24.60 billion by 2032, according to a new study by Polaris Market Research. The report "Global Hormonal Contraceptive Market Size, Share, Trends, Industry Analysis Report: By Product (Pills, Skin Patches, Intrauterine Devices, Hormonal Implants, Vaginal Rings, and Others), By Hormone, By Distribution Channel, and By Region (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) - Market Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global hormonal contraceptive market is experiencing robust growth, driven by increasing awareness about family planning and reproductive health, rising adoption of hormonal contraceptives as a reliable method of birth control, and advancements in contraceptive technology. Key drivers include the growing emphasis on women's health and empowerment, supportive government initiatives and policies promoting contraceptive access, and the rising prevalence of sexually transmitted infections (STIs), which encourages preventive measures. Trends in the market show a shift towards innovative hormonal contraceptives, such as long-acting reversible contraceptives (LARCs), and a rising demand for personalized and convenient options like oral contraceptives and hormonal patches.

The hormonal contraceptive market in emerging markets is experiencing significant growth, driven by advancements in healthcare infrastructure and improving economic conditions. Also, investment in healthcare systems, access to a variety of contraceptive options is expanding, making hormonal contraceptives more widely available. Enhanced economic stability allows more individuals to afford and prioritize family planning services. Additionally, increased awareness and education about reproductive health contribute to higher demand. Governments and organizations are also focusing on improving access through public health initiatives and subsidies, further boosting availability. This growing market reflects a positive shift towards better reproductive health options and empowerment for women in emerging economies.

Hormonal Contraceptive Market Report Highlight

Oral contraceptive pills remain the dominant segment due to their widespread use, well-established efficacy, and long-standing consumer familiarity.

Progestin-Only Contraceptives, which include methods like progestin-only pills, implants, and injections, are increasingly popular due to their suitability for women who cannot use estrogen or prefer a single-hormone approach.

Retail pharmacies currently dominate the market due to their widespread accessibility and convenience for consumers.

The highest-growing segment is hospital pharmacies. This growth is fueled by increasing healthcare access and a rising focus on comprehensive reproductive health services within clinical settings.

North America dominates the market, while Asia-Pacific is expected to witness the highest growth rate.

Polaris Market Research has segmented the Hormonal Contraceptive market report based on product, hormone, distribution channel and region

Hormonal Contraceptive, Product Outlook (Revenue - USD Billion, 2019 - 2032)

Pills
Skin Patches
Intrauterine Devices
Hormonal Implants
Vaginal Rings
Others

Hormonal Contraceptive, Hormone Outlook (Revenue - USD Billion, 2019 - 2032)

Progestin Only
Combined Hormone Contraceptives

Hormonal Contraceptive, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

Hospital Pharmacies
Retail Pharmacies
Others

Hormonal Contraceptive, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia-Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia-Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM2570

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Hormonal Contraceptive Market Insights

4.1. Hormonal Contraceptive Market - Market Snapshot
4.2. Hormonal Contraceptive Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Demand for Long-Acting Reversible Contraceptives (LARCs) Is Driving the Market Growth
  - 4.2.1.2. Shift Towards Personalized and Convenient Contraceptive Options Propels the Market
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Health Concerns and Side Effects is hindering the Hormonal Contraceptive Market Growth
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Hormonal Contraceptive Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Hormonal Contraceptive Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
5.3. Pills
- 5.3.1. Global Hormonal Contraceptive Market, by Pills, by Region, 2019-2032 (USD Billion)
5.4. Skin Patches
- 5.4.1. Global Hormonal Contraceptive Market, by Skin Patches, by Region, 2019-2032 (USD Billion)
5.5. Hormonal Implants
- 5.5.1. Global Hormonal Contraceptive Market, by Hormonal Implants, by Region, 2019-2032 (USD Billion)
5.6. Vaginal Rings
- 5.6.1. Global Hormonal Contraceptive Market, by Vaginal Rings, by Region, 2019-2032 (USD Billion)
5.7. Skin Patches
- 5.7.1. Global Hormonal Contraceptive Market, by Skin Patches, by Region, 2019-2032 (USD Billion)
5.8. Others
- 5.8.1. Global Hormonal Contraceptive Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Hormonal Contraceptive Market, by Hormone

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
6.3. Progestin Only
- 6.3.1. Global Hormonal Contraceptive Market, by Progestin Only, by Region, 2019-2032 (USD Billion)
6.4. Combined Hormone Contraceptives
- 6.4.1. Global Hormonal Contraceptive Market, by Combined Hormone Contraceptives, by Region, 2019-2032 (USD Billion)

7. Global Hormonal Contraceptive Market, by Distribution Channel

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
7.3. Hospital Pharmacies
- 7.3.1. Global Hormonal Contraceptive Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Billion)
7.4. Retail Pharmacies
- 7.4.1. Global Hormonal Contraceptive Market, by Retail Pharmacies, by Region, 2019-2032 (USD Billion)
7.5. Others
- 7.5.1. Global Hormonal Contraceptive Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Hormonal Contraceptive Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Hormonal Contraceptive Market Assessment, By Geography, 2019-2032 (USD Billion)
8.3. Hormonal Contraceptive Market - North America
- 8.3.1. North America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.3.2. North America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.3.3. North America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.4. Hormonal Contraceptive Market - U.S.
  - 8.3.4.1. U.S.: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.3.4.2. U.S.: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.3.4.3. U.S.: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.5. Hormonal Contraceptive Market - Canada
  - 8.3.5.1. Canada: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.3.5.2. Canada: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.3.5.3. Canada: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
8.4. Hormonal Contraceptive Market - Europe
- 8.4.1. Europe: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.4.2. Europe: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.4.3. Europe: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.4. Hormonal Contraceptive Market - UK
  - 8.4.4.1. UK: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.4.4.2. UK: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.4.4.3. UK: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.5. Hormonal Contraceptive Market - France
  - 8.4.5.1. France: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.4.5.2. France: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.4.5.3. France: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.6. Hormonal Contraceptive Market - Germany
  - 8.4.6.1. Germany: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.4.6.2. Germany: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.4.6.3. Germany: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.7. Hormonal Contraceptive Market - Italy
  - 8.4.7.1. Italy: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.4.7.2. Italy: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.4.7.3. Italy: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.8. Hormonal Contraceptive Market - Spain
  - 8.4.8.1. Spain: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.4.8.2. Spain: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.4.8.3. Spain: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.9. Hormonal Contraceptive Market - Netherlands
  - 8.4.9.1. Netherlands: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.4.9.2. Netherlands: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.4.9.3. Netherlands: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.10. Hormonal Contraceptive Market - Russia
  - 8.4.10.1. Russia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.4.10.2. Russia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.4.10.3. Russia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.11. Hormonal Contraceptive Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.4.11.2. Rest of Europe: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.4.11.3. Rest of Europe: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
8.5. Hormonal Contraceptive Market - Asia Pacific
- 8.5.1. Asia Pacific: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.4. Hormonal Contraceptive Market - China
  - 8.5.4.1. China: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.5.4.2. China: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.5.4.3. China: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.5. Hormonal Contraceptive Market - India
  - 8.5.5.1. India: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.5.5.2. India: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.5.5.3. India: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.6. Hormonal Contraceptive Market - Malaysia
  - 8.5.6.1. Malaysia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.5.6.2. Malaysia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.5.6.3. Malaysia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.7. Hormonal Contraceptive Market - Japan
  - 8.5.7.1. Japan: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.5.7.2. Japan: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.5.7.3. Japan: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.8. Hormonal Contraceptive Market - Indonesia
  - 8.5.8.1. Indonesia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.5.8.2. Indonesia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.5.8.3. Indonesia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.9. Hormonal Contraceptive Market - South Korea
  - 8.5.9.1. South Korea: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.5.9.2. South Korea: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.5.9.3. South Korea: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.10. Hormonal Contraceptive Market - Australia
  - 8.5.10.1. Australia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.5.10.2. Australia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.5.10.3. Australia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.11. Hormonal Contraceptive Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
8.6. Hormonal Contraceptive Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.4. Hormonal Contraceptive Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.5. Hormonal Contraceptive Market - UAE
  - 8.6.5.1. UAE: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.6.5.2. UAE: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.6.5.3. UAE: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.6. Hormonal Contraceptive Market - Israel
  - 8.6.6.1. Israel: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.6.6.2. Israel: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.6.6.3. Israel: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.7. Hormonal Contraceptive Market - South Africa
  - 8.6.7.1. South Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.6.7.2. South Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.6.7.3. South Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.8. Hormonal Contraceptive Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
8.7. Hormonal Contraceptive Market - Latin America
- 8.7.1. Latin America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
- 8.7.2. Latin America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.4. Hormonal Contraceptive Market - Mexico
  - 8.7.4.1. Mexico: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.7.4.2. Mexico: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.7.4.3. Mexico: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.5. Hormonal Contraceptive Market - Brazil
  - 8.7.5.1. Brazil: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.7.5.2. Brazil: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.7.5.3. Brazil: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.6. Hormonal Contraceptive Market - Argentina
  - 8.7.6.1. Argentina: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.7.6.2. Argentina: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.7.6.3. Argentina: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.7. Hormonal Contraceptive Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Bayer AG
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Pfizer Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Merck & Co., Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Johnson & Johnson
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. AbbVie Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. GlaxoSmithKline plc
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Mylan N.V.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Teva Pharmaceutical Industries Ltd.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Novartis AG
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. HRA Pharma
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Mithra Pharmaceuticals
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Celgene Corporation
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
10.13. Allergan plc
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
10.14. Procter & Gamble Co.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
10.15. Reddy's Laboratories Ltd.
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development